Drugs that contain Ethinyl Estradiol; Levonorgestrel

1. List of Balcoltra drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7838042 AVION PHARMS Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions
Jun, 2027

(4 years from now)

Market Authorisation Date: 09 January, 2018

Treatment: Administration of ferrous bisglycinate tablets

Dosage: TABLET;ORAL

How can I launch a generic of BALCOLTRA before it's patent expiration?
More Information on Dosage

2. List of Loseasonique drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7615545 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jun, 2023

(4 months from now)

US7858605 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jun, 2023

(4 months from now)

US7855190 TEVA BRANDED PHARM Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
Dec, 2028

(5 years from now)

Market Authorisation Date: 24 October, 2008

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

How can I launch a generic of LOSEASONIQUE before it's patent expiration?
More Information on Dosage

3. List of Quartette drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8450299 TEVA BRANDED PHARM Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
Oct, 2025

(2 years from now)

US8415332 TEVA BRANDED PHARM Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
Mar, 2029

(6 years from now)

Market Authorisation Date: 28 March, 2013

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

How can I launch a generic of QUARTETTE before it's patent expiration?
More Information on Dosage

4. List of Seasonique drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7615545 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jun, 2023

(4 months from now)

US7858605 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jun, 2023

(4 months from now)

US7320969 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jan, 2024

(11 months from now)

US7855190 TEVA BRANDED PHARM Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
Dec, 2028

(5 years from now)

Market Authorisation Date: 25 May, 2006

Treatment: Prevention of pregnancy; Prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception

Dosage: TABLET;ORAL

How can I launch a generic of SEASONIQUE before it's patent expiration?
More Information on Dosage

5. List of Twirla drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9050348 AGILE Dermal delivery device
Jul, 2028

(5 years from now)

US8747888 AGILE Dermal delivery device with in situ seal
Jul, 2028

(5 years from now)

US8246978 AGILE Dermal delivery device with reduced loss of its volatile components
Aug, 2028

(5 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Feb 14, 2023

Market Authorisation Date: 14 February, 2020

Treatment: NA

Dosage: SYSTEM;TRANSDERMAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic